46.46.Z - Wholesale of pharmaceutical goods
20.42.Z - Manufacture of perfumes and toilet preparations
46.45.Z - Wholesale of perfume and cosmetics
70.22.Z - Business and other management consultancy activities
72.19.Z - Other research and experimental development on natural sciences and engineering
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
82.30.Z - Organisation of conventions and trade shows
82.99.Z - Other business support service activities not elsewhere classified
85.59.B - Other out-of-school forms of education, not elsewhere classified
86.9 - Other human health activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 135,3 | 214,9 | -86,3 | -140,2 |
EBITDA | 150,4 | 229 | -86,2 | -137,6 |
Short time liabilities | 117,6 | 117,6 | 101,7 | -13,5 |
Equity capital | 613 | 613 | 807,4 | 31,7 |
Operating profit (EBIT) | 150,4 | 229 | -86,2 | -137,6 |
Assets | 731 | 731 | 909,1 | 24,4 |
Net profit (loss) | 121,6 | 201,2 | -86,3 | -142,9 |
Cash | 475,6 | 475,6 | 639,6 | 34,5 |
Net income from sale | 662,6 | 903,7 | 492,5 | -45,5 |
Liabilities and provisions for liabilities | 118 | 118 | 101,7 | -13,8 |
Working assets | 731 | 731 | 909,1 | 24,4 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 19,8 | 32,8 | -10,7 | -43,5 |
Equity capital to total assets | 83,9 | 83,9 | 88,8 | 4,9 |
Gross profit margin | 20,4 | 23,8 | -17,5 | -41,3 |
EBITDA Margin | 22,7 | 25,3 | -17,5 | -42,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 65 | 48 | 75 | 27 |
Current financial liquidity indicator | 6.214328289031982 | 6.214328289031982 | 8.937784194946289 | 2,7 |
Net dept to EBITDA | -3.162020683288574 | -2.076977014541626 | 7.420760631561279 | 9,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane